secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001193125-24-133133
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote reports Q1 revenue $46.8M (+4.4%), net loss narrows to $5.8M; reaffirms 2024 guidance
--------------------------------------------------------------------------------

- Revenue $46.8M (+4.4% YoY); procedure revenue $37.4M (+6.6%).
- Net loss $(5.8)M vs $(21.4)M prior year; EPS $(0.06) vs $(0.39).
- Adjusted EBITDA $14.2M (+8.0%); margin 30.2% (+100bps).
- Gross margin 71.4% (+240bps) on improved mix.
- BioteRx launch progressing; reaffirms FY2024 guidance with H2 acceleration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312524133133/0001193125-24-133133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312524133133/d802970d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-133133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer